Literature DB >> 18467702

Mast cells regulate the magnitude and the cytokine microenvironment of the contact hypersensitivity response.

M Ursula Norman1, John Hwang, Sara Hulliger, Claudine S Bonder, Jun Yamanouchi, Pere Santamaria, Paul Kubes.   

Abstract

The role that mast cells play during contact hypersensitivity (CS) response is unclear because some studies have shown that mast cell-deficient mice have relatively intact CS responses whereas others have shown opposing results. Mast cells secrete a wide range of immunomodulatory mediators and can potentially influence the type of immune response generated in the skin during CS. Therefore, we examined the type of microenvironment generated during CS in both W/Wv mast cell-deficient and wild-type mice in response to different immunizing doses of hapten (oxazolone). The CS response elicited after low-dose oxazolone was significantly diminished in W/Wv mice compared with wild-type mice. Unexpectedly, the CS response elicited in W/Wv mice immunized with high-dose oxazolone was more severe compared with wild-type mice. In addition, after immunization with high-dose oxazolone, the granulocyte infiltrate in W/Wv mice was increased by twofold compared with wild-type mice. A shift in the cytokine milieu toward the expression of type-1 cytokines as well as a significant increase in the local adhesion of neutrophils and CD4 T cells in the microvasculature of the skin was observed after hapten challenge in W/Wv mice immunized with high-dose oxazolone compared with wild-type mice. These results suggest that mast cells can act as regulators and inducers of the inflammatory response depending on immunizing stimulus strength.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467702      PMCID: PMC2408423          DOI: 10.2353/ajpath.2008.070559

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1.

Authors:  Claudine S Bonder; M Ursula Norman; Mark G Swain; Lori D Zbytnuik; Jun Yamanouchi; Pere Santamaria; Maureen Ajuebor; Marko Salmi; Sirpa Jalkanen; Paul Kubes
Journal:  Immunity       Date:  2005-08       Impact factor: 31.745

2.  Invariant NKT cells rapidly activated via immunization with diverse contact antigens collaborate in vitro with B-1 cells to initiate contact sensitivity.

Authors:  Regis A Campos; Marian Szczepanik; Mariette Lisbonne; Atsuko Itakura; Maria Leite-de-Moraes; Philip W Askenase
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

3.  Multichannel fluorescence spinning disk microscopy reveals early endogenous CD4 T cell recruitment in contact sensitivity via complement.

Authors:  M Ursula Norman; Sara Hulliger; Pina Colarusso; Paul Kubes
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

4.  Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B.

Authors:  Michele A Grimbaldeston; Susumu Nakae; Janet Kalesnikoff; Mindy Tsai; Stephen J Galli
Journal:  Nat Immunol       Date:  2007-09-02       Impact factor: 25.606

5.  An hour after immunization peritoneal B-1 cells are activated to migrate to lymphoid organs where within 1 day they produce IgM antibodies that initiate elicitation of contact sensitivity.

Authors:  Atsuko Itakura; Marian Szczepanik; Regis A Campos; Vipin Paliwal; Monika Majewska; Hiroshi Matsuda; Kiyoshi Takatsu; Philip W Askenase
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

6.  Independent regulation of cutaneous lymphocyte-associated antigen expression and cytokine synthesis phenotype during human CD4+ memory T cell differentiation.

Authors:  Y Teraki; L J Picker
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

7.  Delayed-type hypersensitivity in mast cell-deficient mice: dependence on platelets for expression of contact sensitivity.

Authors:  G P Geba; W Ptak; G M Anderson; V Paliwal; R E Ratzlaff; J Levin; P W Askenase
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

8.  Both Th1 and Th2 cells require P-selectin glycoprotein ligand-1 for optimal rolling on inflamed endothelium.

Authors:  Paul R Mangan; Darrell O'Quinn; Laurie Harrington; Claudine S Bonder; Paul Kubes; Dennis F Kucik; Daniel C Bullard; Casey T Weaver
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

9.  P-selectin can support both Th1 and Th2 lymphocyte rolling in the intestinal microvasculature.

Authors:  Claudine S Bonder; M Ursula Norman; Tara Macrae; Paul R Mangan; Casey T Weaver; Daniel C Bullard; Donna-Marie McCafferty; Paul Kubes
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

10.  Expression of selectin ligands on murine effector and IL-10-producing CD4+ T cells from non-infected and infected tissues.

Authors:  Ute Kretschmer; Kerstin Bonhagen; Gudrun F Debes; Hans-Willi Mittrücker; Klaus J Erb; Oliver Liesenfeld; Dietmar Zaiss; Thomas Kamradt; Uta Syrbe; Alf Hamann
Journal:  Eur J Immunol       Date:  2004-11       Impact factor: 5.532

View more
  22 in total

Review 1.  Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils.

Authors:  Stephen J Galli; Niels Borregaard; Thomas A Wynn
Journal:  Nat Immunol       Date:  2011-10-19       Impact factor: 25.606

Review 2.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

3.  Cellular players and role of selectin ligands in leukocyte recruitment in a T-cell-initiated delayed-type hypersensitivity reaction.

Authors:  Cornelia Doebis; Kerstin Siegmund; Christoph Loddenkemper; John B Lowe; Andrew C Issekutz; Alf Hamann; Jochen Huehn; Uta Syrbe
Journal:  Am J Pathol       Date:  2008-08-28       Impact factor: 4.307

4.  Imaging protective mast cells in living mice during severe contact hypersensitivity.

Authors:  Laurent L Reber; Riccardo Sibilano; Philipp Starkl; Axel Roers; Michele A Grimbaldeston; Mindy Tsai; Nicolas Gaudenzio; Stephen J Galli
Journal:  JCI Insight       Date:  2017-05-04

5.  Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis.

Authors:  Alon Y Hershko; Ryo Suzuki; Nicolas Charles; Damiana Alvarez-Errico; Jennifer L Sargent; Arian Laurence; Juan Rivera
Journal:  Immunity       Date:  2011-10-06       Impact factor: 31.745

Review 6.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

7.  Mast cell interleukin-10 drives localized tolerance in chronic bladder infection.

Authors:  Cheryl Y Chan; Ashley L St John; Soman N Abraham
Journal:  Immunity       Date:  2013-02-15       Impact factor: 31.745

8.  Mechanisms of vitamin D₃ metabolite repression of IgE-dependent mast cell activation.

Authors:  Kwok-Ho Yip; Natasha Kolesnikoff; Chunping Yu; Nicholas Hauschild; Houng Taing; Lisa Biggs; David Goltzman; Philip A Gregory; Paul H Anderson; Michael S Samuel; Stephen J Galli; Angel F Lopez; Michele A Grimbaldeston
Journal:  J Allergy Clin Immunol       Date:  2014-01-22       Impact factor: 10.793

Review 9.  New developments in mast cell biology.

Authors:  Janet Kalesnikoff; Stephen J Galli
Journal:  Nat Immunol       Date:  2008-11       Impact factor: 25.606

Review 10.  New models for analyzing mast cell functions in vivo.

Authors:  Laurent L Reber; Thomas Marichal; Stephen J Galli
Journal:  Trends Immunol       Date:  2012-11-02       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.